CIK 0001861107 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Ceribell, Inc.
Sign in to watch- Ticker
- CBLL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471785452
- Phone
- (800) 436-0826
- Business address
- 360 N. PASTORIA AVENUE, SUNNYVALE, CA, 94085
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,415,987
- in 16 filings, $3.9M under 10b5-1 plans
Net −$4,415,987. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Chao Xingjuan −$2.5M President and CEO sold 12% of stake
- Blumberg Scott −$938K Chief Financial Officer sold 20% of stake
- Woo Raymond −$417K Chief Technology Officer sold 8% of stake
- Taylor Joseph Michael −$278K Director sold 21% of stake
- Foehr David −$269K Senior VP, Finance and PAO sold 25% of stake
Reading 16 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-08 | Chao Xingjuan President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23,554 | 101,477 | ||
| 2026-06-02 | Tammenoms Bakker Juliet Director | Grant or award | +7,838 | 23,284 | ||
| 2026-06-02 | Parvizi Josef Director | Grant or award | +7,838 | 23,284 | ||
| 2026-06-02 | Rogers Erica J. Director | Grant or award | +7,838 | 33,054 | ||
| 2026-06-02 | BURKE WILLIAM W Director | Grant or award | +7,838 | 25,229 | ||
| 2026-06-02 | Taylor Joseph Michael Director | Grant or award | +7,838 | 67,073 | ||
| 2026-06-02 | ROBERTSON REBECCA B Director | Grant or award | +7,838 | 26,587 | ||
| 2026-05-22 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −862 | $18.80 | $16K | 37,751 |
| 2026-05-21 | Manni Joseph S. Chief Revenue Officer | Sale | −1,378 | $18.00 | $25K | 56,291 |
| 2026-05-21 | Foehr David Senior VP, Finance and PAO | Sale 10b5-1 | −987 | $18.00 | $18K | 38,613 |
| 2026-05-21 | Woo Raymond Chief Technology Officer | Sale | −1,966 | $18.00 | $35K | 195,682 |
| 2026-05-21 | Blumberg Scott Chief Financial Officer | Sale | −1,387 | $18.00 | $25K | 147,683 |
| 2026-05-21 | Chao Xingjuan President and CEO | Sale | −6,030 | $18.00 | $109K | 830,317 |
| 2026-05-05 | Chao Xingjuan President and CEO | Sale 10b5-1 | −14,000 | $20.12 | $282K | 836,347 |
| 2026-05-05 | Chao Xingjuan President and CEO | Option exercise 10b5-1 | +1,446 | $4.70 | $7K | 837,793 |
| 2026-05-05 | Chao Xingjuan President and CEO | Sale 10b5-1 | −1,446 | $20.12 | $29K | 836,347 |
| 2026-05-05 | Chao Xingjuan President and CEO | Option exercise 10b5-1 | +23,554 | $4.70 | $111K | 859,901 |
| 2026-05-05 | Chao Xingjuan President and CEO | Sale 10b5-1 | −23,554 | $20.09 | $473K | 836,347 |
| 2026-05-05 | Chao Xingjuan President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,446 | 291,602 | ||
| 2026-05-05 | Chao Xingjuan President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −23,554 | 125,031 |
Page 5 of 17 · 330 trades